Australia, Nov. 11 -- Theradaptive Inc., owns the trademark (2545668) for 'AMP2' till May 7, 2035.
Status: registered:
Registered/protected
Classes: 1 [targetable bone morphogenetic proteins for use as an inducer of regenerative bone growth media, other than for medical or veterinary purposes] and 10 [Medical and surgical instruments for use in bone and joint surgery, regeneration, reconstruction, and augmentation; none of the foregoing being: Implantable scaffolds comprising synthetic materials for maintaining tissue contour; medical implants consisting of synthetic materials; synthetic bone grafts; medical implants comprising natural, non-living materials; implantable scaffolds comprising synthetic materials, namely, fusion cages for sp...